Search Results - "Ringwalt, Emily M"
-
1
Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors
Published in Frontiers in immunology (25-06-2024)“…Malignant peripheral nerve sheath tumors (MPNST) pose a significant therapeutic challenge due to high recurrence rates after surgical resection and a largely…”
Get full text
Journal Article -
2
Corrigendum: Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors
Published in Frontiers in immunology (09-07-2024)“…[This corrects the article DOI: 10.3389/fimmu.2024.1384623.]…”
Get full text
Journal Article -
3
Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma
Published in Molecular Therapy: Oncology (19-12-2024)“…We previously reported that the DNA alkylator and transcriptional-blocking chemotherapeutic agent trabectedin enhances oncolytic herpes simplex…”
Get full text
Journal Article -
4
Progress in sarcomas: Highlights from the 2023 annual meetingof the Connective Tissue Oncology Society
Published in Molecular Therapy: Oncology (21-03-2024)Get full text
Journal Article